These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 61477)

  • 1. D-penicillamine-induced IgA deficiency in Wilson's disease.
    Proesmans W; Jaeken J; Eeckels R
    Lancet; 1976 Oct; 2(7989):804-5. PubMed ID: 61477
    [No Abstract]   [Full Text] [Related]  

  • 2. IgA deficiency during D-penicillamine treatment.
    Hjalmarson O; Hanson LA; Nilsson LA
    Br Med J; 1977 Feb; 1(6060):549. PubMed ID: 843798
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-induced IgA deficiency in rheumatoid arthritis.
    Stanworth DR; Williamson JP; Shadforth M; Felix-Davies D; Thompson R
    Lancet; 1977 May; 1(8019):1001-2. PubMed ID: 67433
    [No Abstract]   [Full Text] [Related]  

  • 4. IgA deficiency during penicillamine treatment.
    Forrest RD; Boström H; Dahlberg PA
    Br Med J; 1977 Mar; 1(6063):777. PubMed ID: 851732
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immune deficiency during D-penicillamine treatment ].
    Michel FB; Bousquet J; Robinet-Levy M; Mary P
    Nouv Presse Med; 1977 Nov; 6(38):3546-7. PubMed ID: 600728
    [No Abstract]   [Full Text] [Related]  

  • 6. [D-penicillamine-induced IgA deficiency in the therapy of Wilson's disease].
    Ibel H; Feist D; Endres W; Belohradsky BH
    Klin Padiatr; 1990; 202(6):427-9. PubMed ID: 2266710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute lymphoblastic leukemia in a patient receiving penicillamine for Wilson's disease.
    Gilman PA; Holtzman NA
    JAMA; 1982 Jul; 248(4):467-8. PubMed ID: 6953259
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
    Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
    J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The detection of antibodies against D-penicillamine. 3. Detection of antibodies against D-penicillamine in the serum of patients with Wilson's disease treated with D-penicillamine--preliminary results].
    Trautmann B; Storch W
    Pharmazie; 1986 Feb; 41(2):126-7. PubMed ID: 3523546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term treatment of Wilson's disease with D-penicillamine. Report on 20 cases].
    Lange J
    Dtsch Med Wochenschr; 1967 Sep; 92(37):1657-62. PubMed ID: 6054323
    [No Abstract]   [Full Text] [Related]  

  • 11. [On hepatolenticular degeneration (Wilson's disease). II. Treatment of 2 cases of Wilson's disease for 8 months with D-penicillamine].
    Germinario L; Campanella G; D'Addabbo A
    Acta Neurol (Napoli); 1971; 26(4):423-35. PubMed ID: 5132824
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of long-term treatment with d-penicillamine on the humoral immune response in patients with Wilson's disease.
    Czlonkowska A
    Mater Med Pol; 1976; 8(1):48-50. PubMed ID: 1263584
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pemphigus in a patient treated with penicillamine for Wilson's disease].
    Degos R; Touraine R; Belaïch S; Revuz J
    Bull Soc Fr Dermatol Syphiligr; 1969; 76(6):751-3. PubMed ID: 5384189
    [No Abstract]   [Full Text] [Related]  

  • 14. Penicillamine-induced arthropathy in Wilson's disease.
    Walshe JM; Golding DN
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):4-6. PubMed ID: 122670
    [No Abstract]   [Full Text] [Related]  

  • 15. Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease.
    Siafakas CG; Jonas MM; Alexander S; Herrin J; Furuta GT
    Am J Gastroenterol; 1998 Dec; 93(12):2544-6. PubMed ID: 9860423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systemic lupus erythematosus induced by d-penicillamine in Wilson's disease: apropos of a case].
    López-Guerra N; Alvarez Lario B; García-Moncó C; Peña Sagredo JL
    Med Clin (Barc); 1987 Apr; 88(13):552-4. PubMed ID: 3586738
    [No Abstract]   [Full Text] [Related]  

  • 17. Penicillamine in Wilson's disease.
    May PM; Jones DC; Williams DR
    Lancet; 1982 Jul; 2(8292):273. PubMed ID: 6124700
    [No Abstract]   [Full Text] [Related]  

  • 18. [D-penicillamin-induced IgA-deficiency (author's transl)].
    Götze H
    Klin Padiatr; 1979 Jul; 191(4):433-5. PubMed ID: 314018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elastosis perforans serpiginosa secondary to D-penicillamine treatment in a Wilson's disease patient.
    Deguti MM; Mucenic M; Cancado EL; Tietge UJ
    Am J Gastroenterol; 2002 Aug; 97(8):2153-4. PubMed ID: 12190204
    [No Abstract]   [Full Text] [Related]  

  • 20. Epileptic status immediately after initiation of D-penicillamine therapy in a patient with Wilson's disease.
    Berger B; Mader I; Damjanovic K; Niesen WD; Stich O
    Clin Neurol Neurosurg; 2014 Dec; 127():122-4. PubMed ID: 25459257
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.